Profile
Dr. Ali Chaari is an Associate Professor of Biology at Weill Cornell Medicine–Qatar with an interest in the field of biochemistry and translational biomedical research. He is a Fellow of the Royal Society of Biology (FRSB). He received his PhD in Biochemistry and Biophysics from Versailles University (France), following engineering training in biological sciences in Tunisia.
Dr. Chaari’s work integrates research, teaching, and academic leadership, with a focus on advancing biochemistry education and research capacity. At Weill Cornell Medicine-Qatar, he contributes to curriculum development and delivers teaching across the premedical and medical programs. His teaching approach emphasizes case-based learning, research integration, and the use of innovative technologies to enhance student engagement and scientific understanding.
His research program lies at the intersection of chemical biology and biomedicine, with particular focus on protein and peptide aggregation, amyloid-related diseases, microbiome-based interventions, and metabolic and neurodegenerative disorders. He has led and contributed to multiple funded research projects and has authored numerous peer-reviewed publications and conference presentations. He is also committed to mentoring students and trainees, supporting their development into independent researchers.
Dr. Chaari is actively engaged in institutional and professional service. He serves as Secretary of the American Chemical Society Qatar Chapter and contributes to academic committees, outreach initiatives, and regional capacity-building efforts. He is also involved in editorial and peer-review activities for international scientific journals.
His contributions have been recognized through multiple awards for excellence in teaching, research mentorship, and outreach. Through his work, Dr. Chaari continues to advance interdisciplinary research, promote innovation in science education, and contribute to the development of future scientists in Qatar and beyond
Selected Publications
- Sedighi M, Shahabi MH, Amanollahi A, Alam K, Shemehsavar S, Shirzadi Z, Sabatini S, Khatoonabadi AR, Prina M, Hosseini AA, Burley CV, Dunne J, Mahinrad S, Dajani I, Martins RN, Stephan BCM, Chaari A, Sohrabi HR. (2026). Prevalence of dementia in selected Middle East and North Africa (MENA) countries: A systematic review and meta-analysis. Alzheimer’s & Dementia, 22(1), e71109. DOI: 10.1002/alz.71109.
- Kaul R, Paul P, Harfouche M, Saliba R, Chaari A. (2024). Microbiome-modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta-analysis, and meta-regression of clinical trials. Diabetes/Metabolism Research and Reviews, 40(2), e3675. DOI: 10.1002/dmrr.3675.
- Paul P, Kaul R, Harfouche M, Arabi M, Al-Najjar Y, Sarkar A, Saliba R, Chaari A. (2022). The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: A systematic review, meta-analysis, and meta-regression of clinical trials. Pharmacological Research, 185, 106520. DOI: 10.1016/j.phrs.2022.106520.
- Chaari A, Saikia N, Paul P, Yousef M, Ding F, Ladjimi M. (2024). Experimental and computational investigation of the effect of Hsc70 structural variants on inhibiting amylin aggregation. Biophysical Chemistry, 309, 107235. DOI: 10.1016/j.bpc.2024.107235.
-
Chaari A. (2020). Inhibition of human islet amyloid polypeptide aggregation and cellular toxicity by oleuropein and derivatives from olive oil. International Journal of Biological Macromolecules, 162, 284–300. DOI: 10.1016/j.ijbiomac.2020.06.170.
Books
- Chaari A . Chaperones as a Novel Target Against Amyloids in Parkinson’s Disease: LAP LAMBERT Academic Publishing; 2014.
-
·Chaari A. Produits Naturels VERSUS Amyloides et Amyloses: Produits naturels et maladies Dégénératives Presses Académiques Francophones; 2014.
Link for full publication list:
1-https://www.researchgate.net/profile/Ali-Chaari/research
2-https://scholar.google.com/citations?user=g76OfKIAAAAJ&hl=en